Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

27
Diabetes Mellitus Fifth Stage-Medicine Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management

Transcript of Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Page 1: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Diabetes MellitusFifth Stage-Medicine

Dr. Sarbast FakhradinMBChB, MSc Diabetes Care & Management

Page 2: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Diabetes mellitus It is a clinical syndrome characterised by hyperglycaemia caused by absolute

or relative deficiency of insulin and this affects the metabolism of

carbohydrate, protein and fat, and can cause significant disturbance of water

and electrolyte homeostasis.

Complications:

1. Acute metabolic decompensation.

2. Chronic complications affecting the eye, the kidney and the nervous

system.

Page 3: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Epidemiology

Worldwide prevalence is 366 million patients & its rising, mainly type 2.

UK is around 4%, but is much higher in the Middle and Far East (11-30%).

Page 4: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

History of Diabetes:• 350 A.D. : "water tasters" diagnosed diabetes by tasting the urine.

• 1675 : the word "mellitus," meaning honey, was added to the name "diabetes," meaning siphon.

• 1800s: chemical tests to detect the presence of sugar in the urine.

• The first diabetes treatment involved prescribed exercise (horseback riding)

• 1700s and 1800s: dietary changes could help manage diabetes

• In 1889 researchers in France, showed that the removal of a dog's pancreas could induce diabetes.

• In 1900s a German scientist, found that injecting pancreatic extract into patients could help control diabetes. • In 1920 Frederick Banting, a physician from Canada, first had the idea to use insulin to treat diabetes in lab, 1922 in human, then awarded the Nobel prize.

Page 5: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Classification of DM:Primary: Type 1 (A or B) & Type 2

Other specific types:•Genetic defects of β-cell function/insulin action• Pancreatic disease (pancreatitis, pancreatectomy, neoplastic disease, cystic fibrosis, haemochromatosis) • Excess endogenous production of hormonal antagonists to insulin (growth hormone; glucocorticoids; glucagon; catecholamines; thyroid hormones) • Drug-induced (corticosteroids, thiazide, phenytoin) • Viral infections (congenital rubella, mumps, Coxsackie virus B) • Associated with genetic syndromes (Down's syndrome; Klinefelter's syndrome; Turner's syndrome; DIDMOAD (Wolfram's syndrome)-diabetes insipidus, diabetes mellitus, optic atrophy, nerve deafness; Friedreich's ataxia; myotonic dystrophy)

Gestational diabetesLADA & MODY

Page 6: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Metabolic actions of insulin

Increase (anabolic effects) Decrease (anticatabolic effects)

Carbohydrate metabolism Carbohydrate metabolism

Glucose transport (muscle, adipose tissue) GluconeogenesisGlycogenolysis

Glucose phosphorylation

Glycogenesis

Glycolysis

Pyruvate dehydrogenase activity

Pentose phosphate shunt

Lipid metabolism Lipid metabolism

Triglyceride synthesis Lipolysis

Fatty acid synthesis (liver) Lipoprotein lipase (muscle)

Lipoprotein lipase activity (adipose tissue) KetogenesisFatty acid oxidation (liver)

Protein metabolism Protein metabolism

Amino acid transport Protein degradation

Protein synthesis

Page 7: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Pancreatic structure and endocrine function:

Page 8: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Mechanisms of glucose-stimulated insulin secretion

Page 9: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Cont.

Page 10: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Aetiology & pathogenesis of diabetes

Type 1 DM:Pathology:

•T cell-mediated autoimmune destruction of the β cells in

pancreas.

• Insulitis: recurrent infiltration of islets with mononuclear

cells

Patchiness of the lesion.

• β-cell specificity of the destructive process, with the

glucagon and other hormone-secreting cells in the islet

remaining intact.

• Islet cell antibodies (glutamic acid decarboxylase (GAD))

can be detected.

• Associated with other autoimmune disorders , including

thyroid disease, coeliac disease, Addison's disease ,

pernicious anaemia, & vitiligo.

Page 11: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

.

Honeymoon period: its occur after initial clinical presentation of type 1 DM during which time glycemic control is achieved with modest doses of insulin or rarely insulin isnt needed

Genetic Predisposition:It is account for about one-third of the susceptibility to type 1 diabetes. Short arm of chromosome 6 (Polygenetic inheritance). HLA haplotypes DR3 and/or DR4.Concordance rate between monozygotic twins is less than 40%.

Page 12: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Environmental Factors:

1. Infection: A. Hygiene hypothesis : reduced exposure to microorganisms in early childhoods limits maturation of immune system and increases susceptibility to autoimmune disease.

B. viral infection: mumps, Coxsackie B4, retroviruses, rubella (in utero), cytomegalovirus and Epstein-Barr virus. 2. Stress

3. Dietary factors: Various nitrosamines (found in smoked and cured meats), coffee, & cow’s milk have been proposed as potentially diabetogenic .

4. Immunological factors: Hyperglycaemia accompanied by the classical symptoms of diabetes occurs only when 70-90% of β cells have been destroyed.

Page 13: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Type 2 DM:Pathology: Insulin resistance & β-cell failure•It is a complex condition there is a combination of insulin resistance in liver and muscle together with impaired pancreatic β-cell function leading to 'relative' insulin deficiency.

•Intra-abdominal 'central' adipose tissue is metabolically active, and releases large quantities of FFAs, cytokines, & adipokines which act on specific receptors to influence sensitivity to insulin.

•Sedentary lifestyle leads to obesity & more insulin-resistant.

•There might be fatty infiltration of the liver (non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH).

•At the time of diagnosis, around 50% of β-cell function has been lost.

Page 14: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

•Some pathological changes are typical such as is deposition of amyloid. Heavy deposition of islets with amyloid is rare without diabetes, but small quantities are very common in elderly non diabetic patients.

•Hyperglycemia & elevated FFA are toxic to β-cell•However, while β-cell numbers are reduced, α-cell mass is unchanged and glucagon secretion is increased, which may contribute to the hyperglycaemia.

Genetic predisposition:Its not HLA linked & autoimmunity or viral infections are less significant Concordance rates for type 2 diabetes might reach 100%A mutation of the glucokinase gene is associated with some cases of the uncommon syndrome of maturity onset diabetes in the young (MODY), constitute less than 5% of all cases of type 2 diabetes

Page 15: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Environmental factors:

Diet & obesity:

Type 2 diabetes is associated with overeating, especially when

combined with obesity and underactivity.

The risk of developing type 2 diabetes increases tenfold in

people with a body mass index (BMI) > 30 kg/m2. Obesity

probably acts as a diabetogenic factor (through increasing

resistance to the action of insulin) only in those who are

genetically predisposed both to insulin resistance and to β-cell

failure. Sweet foods rich in refined carbohydrate consumed

frequently may increase the demand for insulin secretion,

while high-fat foods may increase FFAs and exacerbate insulin

resistance. 

Page 16: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Environmental factors: Cont.

 

Age: Type 2 diabetes is more common in the middle-aged and

elderly.

Pregnancy:

During normal pregnancy, insulin sensitivity is reduced through

the action of placental hormones and this affects glucose

tolerance. The insulin-secreting cells of the pancreatic islets

may be unable to meet this increased demand in women

genetically predisposed to develop diabetes. The term

'gestational diabetes' refers to hyperglycaemia occurring for

the first time during pregnancy. Repeated pregnancy increases

the likelihood of developing irreversible diabetes, particularly

in obese women; 80% of women with gestational diabetes

ultimately develop permanent diabetes.

Page 17: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

α-Cells (glucagon)

Normal

T2DM

β-Cells(insulin)

• Disorganised and misshapen • Marked reduction in β-cell number • Amyloid plaques

Amyloid plaque

Changes in Pancreatic Islet Morphology Represent Underlying Functional Defects

Page 18: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Therefore the main etiologies of type 2 DM are:

1. Relative insulin deficiency

2. Increase hepatic production of glucose.

3. Insulin resistance which usually accompanies obesity this includes:

•Abnormal insulin molecule

•An excessive amount of circulating antagonists.

•Target tissue defect(common cause)

Page 19: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Natural History of type 2 DM:

Page 20: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Some facts:1. 2-6 fold increased risk of heart disease,

stroke and peripheral vascular disease.

2. 60% will die of cardiovascular problems.

3. 60-80% are hypertensive.

4. 60-70% have some kind of peripheral neuropathy.

Page 21: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Some more facts5. Up to 50% of all amputations occur in diabetic patients.

6. Is the single commonest (13.8%) cause of blindness in those of working age.

7. Nephropathy occurs in about 25%

8. Accounts for 8-10% of healthcare budget.

Page 22: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Xanthelasma

Page 23: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Arcus Senilis

Page 24: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Diabetic Retinopathy

Page 25: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Acanthosis nigricans

Page 26: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.
Page 27: Dr. Sarbast Fakhradin MBChB, MSc Diabetes Care & Management.

Thank you

Questions?